• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钙通道 TRPV6 通过 NFATC2IP 促进乳腺癌转移。

Calcium channel TRPV6 promotes breast cancer metastasis by NFATC2IP.

机构信息

Basic Medical Institute, Hongqiao International Institute of Medicine, Tongren Hospital, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China; Department of Laboratory Medicine, Shanghai General Hospital Jiading Branch, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Basic Medical Institute, Hongqiao International Institute of Medicine, Tongren Hospital, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.

出版信息

Cancer Lett. 2021 Oct 28;519:150-160. doi: 10.1016/j.canlet.2021.07.017. Epub 2021 Jul 13.

DOI:10.1016/j.canlet.2021.07.017
PMID:34265397
Abstract

Calcium channel TRPV6 upregulation is associated with poor prognosis of breast cancer by promoting invasion and metastasis, and TRPV6 is a potential target for breast cancer therapy. However, the mechanism by which TRPV6 promotes breast metastasis remains unclear. Here, we report that TRPV6 expression is upregulated in metastatic breast cancers and that TRPV6 overexpression or upregulation accelerates primary breast cancer cell migration. In contrast, TRPV6 suppression decreases cell migration. Mechanistically, TRPV6 activates NFATC2 by increasing NFATC2IP phosphorylation at Ser204, and CDK5 is a candidate kinase that may perform this phosphorylation. Consequently, activated NFATC2 increases breast cancer metastasis by upregulating ADAMTS6 expression. These observations suggest that TRPV6 increases NFATC2 transcriptional activity by increasing NFATC2IP phosphorylation, which consequently upregulates ADAMTS6 expression to promote breast cancer metastasis.

摘要

钙通道 TRPV6 的上调与乳腺癌不良预后相关,通过促进侵袭和转移,TRPV6 是乳腺癌治疗的潜在靶点。然而,TRPV6 促进乳腺癌转移的机制尚不清楚。在这里,我们报告 TRPV6 的表达在转移性乳腺癌中上调,并且 TRPV6 的过表达或上调加速了原发性乳腺癌细胞的迁移。相比之下,TRPV6 的抑制降低了细胞迁移。在机制上,TRPV6 通过增加 NFATC2IP 在 Ser204 处的磷酸化来激活 NFATC2,而 CDK5 是可能执行这种磷酸化的候选激酶。因此,激活的 NFATC2 通过上调 ADAMTS6 的表达来增加乳腺癌的转移。这些观察结果表明,TRPV6 通过增加 NFATC2IP 的磷酸化来增加 NFATC2 的转录活性,从而上调 ADAMTS6 的表达以促进乳腺癌转移。

相似文献

1
Calcium channel TRPV6 promotes breast cancer metastasis by NFATC2IP.钙通道 TRPV6 通过 NFATC2IP 促进乳腺癌转移。
Cancer Lett. 2021 Oct 28;519:150-160. doi: 10.1016/j.canlet.2021.07.017. Epub 2021 Jul 13.
2
Calcium channel TRPV6 as a potential therapeutic target in estrogen receptor-negative breast cancer.钙通道 TRPV6 作为雌激素受体阴性乳腺癌的潜在治疗靶点。
Mol Cancer Ther. 2012 Oct;11(10):2158-68. doi: 10.1158/1535-7163.MCT-11-0965. Epub 2012 Jul 17.
3
Tamoxifen inhibits TRPV6 activity via estrogen receptor-independent pathways in TRPV6-expressing MCF-7 breast cancer cells.他莫昔芬通过雌激素受体非依赖性途径抑制 MCF-7 乳腺癌细胞中 TRPV6 的活性。
Mol Cancer Res. 2009 Dec;7(12):2000-10. doi: 10.1158/1541-7786.MCR-09-0188. Epub 2009 Dec 8.
4
TRPV6 calcium channel directs homeostasis of the mammary epithelial sheets and controls epithelial mesenchymal transition.瞬时受体电位香草酸亚型 6(TRPV6)钙通道调控乳腺上皮细胞层的稳态并控制上皮-间充质转化。
Sci Rep. 2020 Sep 7;10(1):14683. doi: 10.1038/s41598-020-71645-z.
5
Regulation of calcium influx and signaling pathway in cancer cells via TRPV6-Numb1 interaction.通过 TRPV6-Numb1 相互作用调节癌细胞内钙内流和信号通路。
Cell Calcium. 2013 Feb;53(2):102-11. doi: 10.1016/j.ceca.2012.10.005. Epub 2012 Nov 7.
6
Auto-inhibitory intramolecular S5/S6 interaction in the TRPV6 channel regulates breast cancer cell migration and invasion.TRPV6通道中自抑制性分子内S5/S6相互作用调节乳腺癌细胞的迁移和侵袭。
Commun Biol. 2021 Aug 19;4(1):990. doi: 10.1038/s42003-021-02521-3.
7
The role of TRPV6 in breast carcinogenesis.瞬时受体电位香草酸亚型6(TRPV6)在乳腺癌发生中的作用。
Mol Cancer Ther. 2008 Feb;7(2):271-9. doi: 10.1158/1535-7163.MCT-07-0478. Epub 2008 Feb 1.
8
TRPV6 calcium channel translocates to the plasma membrane via Orai1-mediated mechanism and controls cancer cell survival.瞬时受体电位香草酸亚型6(TRPV6)钙通道通过Orai1介导的机制转运至质膜并控制癌细胞存活。
Proc Natl Acad Sci U S A. 2014 Sep 16;111(37):E3870-9. doi: 10.1073/pnas.1413409111. Epub 2014 Aug 29.
9
RNA interference mediated suppression of TRPV6 inhibits the progression of prostate cancer by modulating cathepsin B and MMP9 expression.RNA 干扰介导的 TRPV6 抑制通过调节组织蛋白酶 B 和 MMP9 表达抑制前列腺癌的进展。
Investig Clin Urol. 2021 Jul;62(4):447-454. doi: 10.4111/icu.20200511. Epub 2021 May 20.
10
ADAMTS6 suppresses tumor progression via the ERK signaling pathway and serves as a prognostic marker in human breast cancer.ADAMTS6通过ERK信号通路抑制肿瘤进展,并作为人类乳腺癌的预后标志物。
Oncotarget. 2016 Sep 20;7(38):61273-61283. doi: 10.18632/oncotarget.11341.

引用本文的文献

1
Targeting TRPV6/CXCR4 complexes prevents castration-resistant prostate cancer metastasis to the bone.靶向TRPV6/CXCR4复合物可预防去势抵抗性前列腺癌向骨转移。
Signal Transduct Target Ther. 2025 Sep 5;10(1):287. doi: 10.1038/s41392-025-02376-8.
2
TRP channels and breast cancer: the role of TRPs in the pathophysiological development.瞬时受体电位通道与乳腺癌:瞬时受体电位通道在病理生理发展中的作用
Front Mol Biosci. 2025 Feb 26;12:1528663. doi: 10.3389/fmolb.2025.1528663. eCollection 2025.
3
Overexpression of TRPV6 Inhibits Coronary Atherosclerosis-Related Inflammatory Response and Cell Apoptosis via the PKA/UCP2 Pathway.
TRPV6的过表达通过PKA/UCP2途径抑制冠状动脉粥样硬化相关的炎症反应和细胞凋亡。
Cardiovasc Ther. 2024 Oct 23;2024:7053116. doi: 10.1155/2024/7053116. eCollection 2024.
4
TRPV2 calcium channel promotes breast cancer progression potential by activating autophagy.瞬时受体电位香草酸亚型2(TRPV2)钙通道通过激活自噬促进乳腺癌进展潜能。
Cancer Cell Int. 2024 Sep 27;24(1):324. doi: 10.1186/s12935-024-03506-y.
5
Voltage-gated sodium channels in cancers.癌症中的电压门控钠通道
Biomark Res. 2024 Jul 25;12(1):70. doi: 10.1186/s40364-024-00620-x.
6
miR-31-5p suppresses myocardial hypertrophy by targeting Nfatc2ip.miR-31-5p 通过靶向 NFATC2IP 抑制心肌肥大。
J Cell Mol Med. 2024 Jun;28(12):e18413. doi: 10.1111/jcmm.18413.
7
Genetic and immune identification and functional analysis of TRPM8 as a potential biomarker for pancreatic adenocarcinoma proliferation.TRPM8 作为胰腺腺癌增殖的潜在生物标志物的遗传和免疫鉴定及功能分析。
Cancer Rep (Hoboken). 2024 Jun;7(6):e2108. doi: 10.1002/cnr2.2108.
8
Function and mechanism of action of the TRPV1 channel in the development of triple-negative breast cancer.瞬时受体电位香草酸亚型 1(TRPV1)通道在三阴性乳腺癌发生发展中的功能和作用机制。
Acta Biochim Biophys Sin (Shanghai). 2024 May 11;56(7):957-962. doi: 10.3724/abbs.2024068.
9
The role of lidocaine in cancer progression and patient survival.利多卡因在癌症进展和患者生存中的作用。
Pharmacol Ther. 2024 Jul;259:108654. doi: 10.1016/j.pharmthera.2024.108654. Epub 2024 May 1.
10
LncRNA LUESCC promotes esophageal squamous cell carcinoma by targeting the miR-6785-5p/NRSN2 axis.长链非编码 RNA LUESCC 通过靶向 miR-6785-5p/NRSN2 轴促进食管鳞状细胞癌。
Cell Mol Life Sci. 2024 Mar 8;81(1):121. doi: 10.1007/s00018-024-05172-9.